Spring 2024 Vol. 14 Issue 01
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Tending Your GardenRemove those things that will hamper your growth during cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
An Extra Set of Eyes and EarsCaregivers’ unique perspectives can enrich conversations with doctors, but it’s not always easy to decide when to speak up.
by K.J. Bannan
-
Policy Matters
Cancer Research Funding Faces Uncertain FutureThe AACR is planning numerous initiatives in 2024 to bolster congressional support.
by Jon Retzlaff, MBA, MPA
-
A Gentler Treatment Course
Patients who speak up when they don’t feel well can help doctors manage side effects caused by chemotherapy.
by Marci A. Landsmann
-
Taking a Shot Against Cancer Recurrences
Early findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.
by Kendall K. Morgan
-
Climate Change and Cancer Care
Cancer centers and their patients face disruptions caused by hurricanes, wildfires and other extreme weather events.
by Cameron Walker
-
Survivor Profile
An Inspiration to OthersKay Kays, a 30-year pancreatic cancer survivor, works to advance research and raise awareness of the disease.
by Lindsey Konkel Neabore
-
Q&A
A Musical Takes on CancerMusician and breast cancer survivor Marcy Marxer reenacts life during cancer treatment, with a comedic twist.
by Tyler Santora
-
Get Involved
Creating ConnectionsChemo Companions ensures people with cancer do not have to be alone during their chemotherapy treatments.
by Thomas Celona
-
Facts and Stats
Breast Cancer Survival Rates Continue to RiseNew report highlights decades of progress, as well as a persisting disparity.
by Thomas Celona
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon